Related Experiment Videos
Monocyte markers and the common acute lymphoblastic leukemia antigen on chronic lymphocytic leukemia cells
Insights
This study analyzed chronic lymphocytic leukemia (CLL) cells for surface markers. Findings reveal specific antigen expressions, aiding in leukemia classification and understanding its B-cell origins.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is a B-cell malignancy.
- Accurate immunophenotyping is crucial for CLL diagnosis and classification.
Purpose of the Study:
- To analyze surface markers on mononuclear cells from 42 CLL patients.
- To characterize antigen expression profiles for better understanding of CLL.
Main Methods:
- Monoclonal antibodies and flow cytofluorimetry were used for surface marker analysis.
- Analysis focused on Ig, HLA-DR, T-cell markers (OKT3-OKT8), and myeloid antigens (OKM1, 63D3).
Main Results:
- All 42 CLL cases were Ig+HLA.DR+ and monoclonal for light chain type.
- 30/42 expressed the common acute lymphocytic leukemia antigen.
- 18/42 showed myeloid antigen expression (OKM1, 63D3).
- 8/42 failed to stain with PI153, an antibody for B-cell CLL.
Conclusions:
- CLL cells exhibit a distinct surface marker profile.
- The presence of myeloid antigens in some CLL cases warrants further investigation.
- PI153 antibody may not identify all B-cell CLL cases.
Abstract:
The mononuclear cells from 42 patients with chronic lymphocytic leukemia (CLL) were analyzed for surface markers using monoclonal antibodies and flow cytofluorimetry. All 42 CLLs were Ig+HLA.DR+OKT3-OKT4-OKT6-OKT8- and monoclonal with respect to light chain type. Thirty of the 42 tumors expressed the common acute lymphocytic leukemia antigen, and cells from 18 leukemias stained with the antibodies OKM1 and 63D3, which are specific for different antigens characteristic of myeloid cells. Eight of the leukemias failed to stain with PI153, which has been reported to recognize all B-cell CLLs.